Study on Safe Conceiving Post-Genetic T Cell Therapy

A small study suggests that women with autoimmune diseases who receive genetically modified T-cell therapy can safely become pregnant after treatment. The results showed that all 14 pregnancies monitored occurred naturally and without complications, and the babies were healthy, exhibiting normal growth and immune indicators, with no evidence of residual modified cells or disease relapse. This is the first study to confirm the safety of pregnancy following treatment with genetically modified T-cells, although research is still in its early stages and requires further validation.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل